Confused? Buy or Sell in volatile market – Analyst report Elanco Animal Health (NYSE:ELAN)

Earnings results for Elanco Animal Health (NYSE:ELAN)

Elanco Animal Health Incorporated is expected* to report earnings on 02/24/2021 before market open. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.09. The reported EPS for the same quarter last year was $0.23.

Analyst Opinion on Elanco Animal Health (NYSE:ELAN)

10 Wall Street analysts have issued ratings and price targets for Elanco Animal Health in the last 12 months. Their average twelve-month price target is $29.28, predicting that the stock has a possible downside of 2.73%. The high price target for ELAN is $41.00 and the low price target for ELAN is $19.00. There are currently 2 sell ratings, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of “Hold.”

Elanco Animal Health has received a consensus rating of Hold. The company’s average rating score is 2.30, and is based on 5 buy ratings, 3 hold ratings, and 2 sell ratings. According to analysts’ consensus price target of $29.28, Elanco Animal Health has a forecasted downside of 2.7% from its current price of $30.10. Elanco Animal Health has only been the subject of 1 research reports in the past 90 days.

Dividend Strength: Elanco Animal Health (NYSE:ELAN)

Elanco Animal Health does not currently pay a dividend. Elanco Animal Health does not have a long track record of dividend growth.

Insiders buying/selling: Elanco Animal Health (NYSE:ELAN)

In the past three months, Elanco Animal Health insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,626,280,000.00 in company stock. Only 0.12% of the stock of Elanco Animal Health is held by insiders. 86.83% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Elanco Animal Health (NYSE:ELAN

Earnings for Elanco Animal Health are expected to grow by 104.55% in the coming year, from $0.44 to $0.90 per share. The P/E ratio of Elanco Animal Health is -52.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Elanco Animal Health is -52.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Elanco Animal Health has a PEG Ratio of 4.13. PEG Ratios above 1 indicate that a company could be overvalued. Elanco Animal Health has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here